BlackRock Fund Advisors’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-2,090,631
| Closed | -$4.24M | – | 4376 |
|
|
2016
Q1 | $4.24M | Sell |
2,090,631
-76,398
| -4% | -$136K | ﹤0.01% | 2824 |
|
|
2015
Q4 | $5.37M | Buy |
2,167,029
+59,017
| +3% | +$175K | ﹤0.01% | 2801 |
|
|
2015
Q3 | $5.48M | Sell |
2,108,012
-3,060
| -0.1% | -$7.97K | ﹤0.01% | 2752 |
|
|
2015
Q2 | $6.63M | Buy |
2,111,072
+45,897
| +2% | +$157K | ﹤0.01% | 2752 |
|
|
2015
Q1 | $5.91M | Buy |
2,065,175
+55,034
| +3% | +$141K | ﹤0.01% | 2752 |
|
|
2014
Q4 | $5.19M | Buy |
2,010,141
+292,096
| +17% | +$1.28M | ﹤0.01% | 2853 |
|
|
2014
Q3 | $12.8M | Sell |
1,718,045
-27,152
| -2% | -$254K | ﹤0.01% | 2213 |
|
|
2014
Q2 | $20.6M | Buy |
1,745,197
+499,029
| +40% | +$5.32M | 0.01% | 2005 |
|
|
2014
Q1 | $14.5M | Buy |
1,246,168
+26,475
| +2% | +$312K | ﹤0.01% | 2187 |
|
|
2013
Q4 | $13.3M | Sell |
1,219,693
-44,809
| -4% | -$441K | ﹤0.01% | 2212 |
|
|
2013
Q3 | $13.6M | Buy |
1,264,502
+149,050
| +13% | +$1.7M | ﹤0.01% | 2177 |
|
|
2013
Q2 | $13.1M | Buy |
+1,115,452
| New | +$11.1M | ﹤0.01% | 2099 |
|
BlackRock Fund Advisors's SZYM Position: Q2 2016 in Review
BlackRock Fund Advisors sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 2,090,631 shares — an estimated $4.24M sold.
BlackRock Fund Advisors first reported a position in SZYM in Q2 2013 and held it in 12 quarters. The position peaked at $20.6M in Q2 2014. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.
- BlackRock Fund Advisors reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
- BlackRock Fund Advisors sold 2,090,631 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $4.24M.
- BlackRock Fund Advisors first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 12 quarters.
- BlackRock Fund Advisors's SOLAZYME INC COM STK (DE) position peaked at $20.6M in Q2 2014.
- 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.
Based on BlackRock Fund Advisors's 13F filing for Q2 2016, filed 10 Aug 2016.